Clinical Trials Update: Nov. 12, 2004
Metastatic Cancer Non-Hodgkin's Lymphoma Multiple Sclerosis
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for patients with a histologic or cytologic diagnosis of locally advanced or metastatic cancer. Prior chemotherapy is allowed. Research site located in San Antonio, TX.
A research study for patients 18 and older who have follicular b-cell non-Hodgkin's lymphoma (NHL) who have never received treatment, or who have relapsed or are resistant to prior chemotherapy. Research site located in Kansas City, KS.
A research study to compare the safety and effectiveness of two currently marketed drugs for the treatment of relapsing-remitting multiple sclerosis (RRMS). Volunteers between 18 and 60 who are diagnosed with RRMS may be eligible. Research site located in Tampa, Fla.
Copyright 2004 CenterWatch. All rights reserved.